Po-amitriptyline 10mg (2021-04-13)

Recall Summary APO-AMITRIPTYLINE 10mg tablets have been recalled across Canada due to a product safety issue. This recall affects all patients or consumers who have this medication. The recall is classified as Class I, meaning there is a serious potential health risk associated with the product.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2021-04-13

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/c0cf92c5-b922-4219-83b5-216178bcbf28